[The clinico-bacteriological and pharmacokinetic evaluation of vancomycin in clinical practice].
Clinical application of vancomycin in 24 patients produced a response in 83.3% of the patients. The drug was active against pneumococcal pneumonia, bronchitis, staphylococcal endocarditis and mastitis. Positive pharmacokinetic parameters of the drug allows introduction of the antibiotic 1-2 times daily.